• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

175镱生产的可行性研究:一种有前景的治疗性放射性核素。

Feasibility study for production of 175Yb: a promising therapeutic radionuclide.

作者信息

Chakraborty Sudipta, Unni P R, Venkatesh Meera, Pillai M R A

机构信息

Chemistry Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai 400 085, India.

出版信息

Appl Radiat Isot. 2002 Sep;57(3):295-301. doi: 10.1016/s0969-8043(02)00100-8.

DOI:10.1016/s0969-8043(02)00100-8
PMID:12201133
Abstract

Owing to its favourable decay characteristics 175Yb (T1/2 = 4.2 d, E beta(max) = 480 keV) can be regarded as a potential radionuclide for therapeutic applications. Production of 175Yb using (174Yb(n, gamma)175Yb) reaction by thermal neutron bombardment on natural ytterbium target is described. The activity of 175Yb produced as well as its radionuclidic purity under different irradiation conditions were determined by gamma-ray spectrometry using an HPGe 4 K MCA system and compared with theoretically calculated values. The radiochemical purity after chemical processing was determined by paper chromatography as well as paper electrophoresis techniques. It is found that 31 Ci/g (1145 GBq/g) of 175Yb can be produced with > 95% radionuclidic purity (with approximately 3% of 169Yb and approximately 2% of 177Lu) by irradiating natural Yb2O3 target at a thermal neutron flux of 3 x 10(13) n/cm2/s for a period of 5 d.

摘要

由于其良好的衰变特性,175镱(半衰期T1/2 = 4.2天,最大β能量Eβ(max) = 480 keV)可被视为一种潜在的治疗用放射性核素。本文描述了通过热中子轰击天然镱靶利用(174镱(n,γ)175镱)反应生产175镱的过程。使用HPGe 4 K MCA系统通过γ射线能谱法测定了在不同辐照条件下产生的175镱的活度及其放射性核素纯度,并与理论计算值进行了比较。化学处理后的放射化学纯度通过纸色谱法和纸电泳技术测定。结果发现,通过在3×10(13) n/cm2/s的热中子通量下辐照天然Yb2O3靶5天,可以生产出放射性核素纯度> 95%(约含3%的169镱和约2%的177镥)的175镱,活度为31 Ci/g(1145 GBq/g)。

相似文献

1
Feasibility study for production of 175Yb: a promising therapeutic radionuclide.175镱生产的可行性研究:一种有前景的治疗性放射性核素。
Appl Radiat Isot. 2002 Sep;57(3):295-301. doi: 10.1016/s0969-8043(02)00100-8.
2
175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints.175镱标记的羟基磷灰石:一种用于小关节放射性滑膜切除术的潜在药物。
Nucl Med Biol. 2006 May;33(4):585-91. doi: 10.1016/j.nucmedbio.2006.02.004. Epub 2006 May 2.
3
Production logistics of 177Lu for radionuclide therapy.用于放射性核素治疗的177镥的生产物流
Appl Radiat Isot. 2003 Aug-Sep;59(2-3):109-18. doi: 10.1016/s0969-8043(03)00158-1.
4
175Yb labeled polyaminophosphonates as potential agents for bone pain palliation.175镱标记的聚氨基膦酸盐作为缓解骨痛的潜在药物。
Appl Radiat Isot. 2004 May;60(5):635-42. doi: 10.1016/j.apradiso.2003.09.016.
5
Feasibility study for production and quality control of Yb-175 as a byproduct of no carrier added Lu-177 preparation for radiolabeling of DOTMP.作为无载体添加的用于DOTMP放射性标记的Lu-177制备副产物的Yb-175生产及质量控制的可行性研究
Australas Phys Eng Sci Med. 2018 Mar;41(1):69-79. doi: 10.1007/s13246-017-0611-x. Epub 2017 Dec 19.
6
Production logistics and radionuclidic purity aspects of 153Sm for radionuclide therapy.用于放射性核素治疗的153Sm的生产物流与放射性核素纯度方面
Nucl Med Commun. 2002 Jan;23(1):83-9. doi: 10.1097/00006231-200201000-00013.
7
Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer.用于肝癌治疗的¹⁷⁷镥标记羟基磷灰石颗粒的制备及初步研究
Nucl Med Biol. 2008 Jul;35(5):589-97. doi: 10.1016/j.nucmedbio.2008.03.003.
8
177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis.177镥-乙二胺四甲基膦酸:一种治疗骨转移引起骨痛的可行姑息治疗药物。
Cancer Biother Radiopharm. 2008 Apr;23(2):202-13. doi: 10.1089/cbr.2007.374.
9
A re-activation model for Yb intensity modulated brachytherapy sources accounting for spatiotemporal isotopic composition.考虑时空同位素组成的 Yb 强度调制近距离治疗源的再激活模型。
Med Phys. 2024 May;51(5):3604-3618. doi: 10.1002/mp.17048. Epub 2024 Apr 1.
10
An electro-amalgamation approach to isolate no-carrier-added 177Lu from neutron irradiated Yb for biomedical applications.采用电偶合法从中子辐照的 Yb 中分离无载体添加的 177Lu,用于生物医学应用。
Nucl Med Biol. 2010 Oct;37(7):811-20. doi: 10.1016/j.nucmedbio.2010.04.082.

引用本文的文献

1
Neutron-activated, plasmonically excitable Fe-Pt-YbO nanoparticles delivering anti-cancer radiation against human glioblastoma cells.经中子活化、具有等离子体激元激发特性的铁-铂-氧化镱纳米颗粒对人胶质母细胞瘤细胞产生抗癌辐射。
iScience. 2023 Aug 18;26(9):107683. doi: 10.1016/j.isci.2023.107683. eCollection 2023 Sep 15.
2
Novel Yb-Poly (L-Lactic Acid) Microspheres for Transarterial Radioembolization of Unrespectable Hepatocellular Carcinoma.用于不可切除肝细胞癌经动脉放射性栓塞的新型镱-聚(L-乳酸)微球
Iran J Pharm Res. 2019 Spring;18(2):569-578. doi: 10.22037/ijpr.2019.1100668.
3
Preparation, Biological Evaluation and Dosimetry Studies of 175Yb-Bis-Phosphonates for Palliative Treatment of Bone Pain.
用于骨痛姑息治疗的175镱双膦酸盐的制备、生物学评价及剂量学研究
Mol Imaging Radionucl Ther. 2015 Oct 5;24(3):110-9. doi: 10.4274/mirt.36036.
4
The elements of life and medicines.生命与药物的元素。
Philos Trans A Math Phys Eng Sci. 2015 Mar 13;373(2037). doi: 10.1098/rsta.2014.0182.
5
(175)Yb-TTHMP for bone pain palliation.用于缓解骨痛的镱-四甲基戊二酸六甲基磷酰胺
Indian J Nucl Med. 2015 Jan-Mar;30(1):90. doi: 10.4103/0972-3919.147561.